tiprankstipranks
Trending News
More News >
Diagonal Bio AB (DE:9F1)
:9F1
Germany Market

Diagonal Bio AB (9F1) Income Statement

Compare
0 Followers

Diagonal Bio AB Income Statement

Last quarter (Q3 2024), Diagonal Bio AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q3, Diagonal Bio AB's net income was kr-1.24M. See Diagonal Bio AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 23.00Kkr 203.00Kkr 407.00Kkr 20.31K
Gross Profit
kr 3.13Mkr 2.05Mkr -85.00Kkr -607.55K
Operating Expenses
kr 14.70Mkr 17.22Mkr 11.58Mkr 708.00K
Depreciation and Amortization
kr 3.00Kkr 15.16Mkr 11.66Mkr 777.33K
EBITDA
kr -11.47Mkr 0.00kr -11.66Mkr 193.97K
Operating Income
kr -11.57Mkr -15.16Mkr -11.66Mkr -607.55K
Other Income/Expenses
kr -112.00Kkr -1.00Mkr 0.00kr 24.19K
Pretax Income
kr -11.68Mkr -16.16Mkr -11.66Mkr -583.36K
Net Income
kr -11.68Mkr -16.16Mkr -11.66Mkr -583.36K
Per Share Metrics
Basic EPS
kr -0.32kr -1.70kr -1.70kr -0.17
Diluted EPS
kr -0.32kr -1.70kr -1.70kr -0.17
Weighted Average Shares Outstanding
36.48M 9.50M 6.88M 3.50M
Weighted Average Shares Outstanding (Diluted)
36.48M 9.50M 6.88M 3.50M
Currency in SEK

Diagonal Bio AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis